Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

XNYS:DNA 4:00:00 PM EDT

12.35

-0.15 (-1.20%)

: $12.69 +0.34 (+2.75%)

Market Cap (Intraday)	785.07M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$21.57 Million
Adjusted EPS	-$1.01

See more estimates

10-Day MA	$11.18
50-Day MA	$8.18
200-Day MA	$8.34

See more pivots

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A Stock, XNYS:DNA

27 Drydock Avenue, 8th floor, Boston, Massachusetts 02210

United States of America

Phone: +1.877.422.5362

Number of Employees: 834

http://www.ginkgobioworks.com

Description

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.